August 2016

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Conditions:   Acute Leukemia;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Diffuse Large B-Cell Lymphoma;   Follicular Lymphoma;   Graft Versus Host Disease;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Myeloproliferative Neoplasm;   Small Lymphocytic Lymphoma
Interventions:   Biological: Thymoglobulin;   Drug: Bortezomib;   Drug: Tacrolimus
Sponsor:   Emory University
Recruiting - verified October 2016

Screening in Oculopharyngeal Muscular Dystrophy

Condition:   Oculopharyngeal Muscular Dystrophy
Interventions:   Device: Iowa Oral Performance Instrument;   Drug: Capsaicin;   Device: Electrical Impedance Myography (EIM);   Procedure: Videofluoroscopic swallowing study;   Other: Swallowing Related Quality of Life Questionnaire;   Other: Functional Oral Intake Scale;   Other: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised;   Other: Eating Assessment Tool-10;   Other: Communicative Effectiveness Survey;   Other: The Center for Neurologic Studies Bulbar Function Scale

Research Shows How Genetic Mutations Disrupt ALS-linked Protein

‘Mechanism by which amyotrophic lateral sclerosis (ALS) mutations cause ALS has been identified by scientists.’ In general, TDP-43 acts like a chaperone for RNA in a cell, binding to it, guiding its processing, transporting it to where it needs to go ...

Brain–computer interfaces for communication and rehabilitation

with a focus on patients who are disabled as a result of amyotrophic lateral sclerosis (ALS), and rehabilitative BCIs for the restoration of movement, particularly in patients with chronic stroke. At the beginning of 21st century, progress in BCI research ...

Pages